Jefferies Upgrades Omnicare (OCR) to Buy
More News related to OCR
- Omnicare (OCR) Declares $0.0225 Quarterly Dividend; 0.4% Yield
- Omnicare Declares Quarterly Cash Dividend
- UBS Starts Numerous Healthcare Stocks: CAH, MCK, ESRX at Buy, PMC, OCR at Neutral
- Omnicare to Present at the Lazard Capital Markets Sixth Annual Healthcare Conference
- Omnicare to Present at the Credit Suisse 18th Annual Healthcare Conference
More News related to Upgrades
- Shares of Brocade (BRCD) Outperforming as Oscar Gruss Upgrades to Buy
- Kinross (KGC) Jumps Higher as Gold Breaks $1,200, JPMorgan Upgrades to Overweight
- Raymond James Upgrades PSS World Medical (PSSI) to Outperform
- Capital One Southcoast Upgrades Penn Virginia (PVA) to Add; Turning Bullish After Data Release
- Raymond James Upgrades CPFL Energia S.A. (CPL) to Outperform
Jefferies & Co. upgrades Omnicare (NYSE: OCR) from Hold to Buy.
Omnicare, Inc., a geriatric pharmaceutical services company, provides pharmaceuticals and related ancillary pharmacy services.
Related Categories
UpgradesStocks Mentioned
+0.30Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
